|
| dbGaP Submitter Subject ID (ID2) | Coriell Sample ID | Consent | Control | Gender | Race | Age | Baseline Max AMD Severity | Final Max AMD Severity |
| AR2_0029 | ED148070 | General Research Use | No | Female | White | 70 | 7 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0132 | ED148293 | General Research Use | No | Female | White | 75 | 7 - AREDS AMD Severity Scale Step 7 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0189 | ED148476 | General Research Use | No | Male | White | 76 | 7 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0307 | ED149320 | General Research Use | No | Female | White | 61 | 7 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0416 | ED149178 | General Research Use | No | Female | White | 78 | 7 - AREDS AMD Severity Scale Step 7 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_0521 | ED148722 | General Research Use | No | Male | White | 63 | 7 - AREDS AMD Severity Scale Step 7 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0528 | ED149390 | General Research Use | No | Female | White | 79 | 7 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0660 | ED148912 | General Research Use | No | Female | White | 57 | 7 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0754 | ED148545 | General Research Use | No | Male | White | 67 | 7 - AREDS AMD Severity Scale Step 6 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_0803 | ED149381 | General Research Use | No | Female | Other | 50 | 7 - AREDS AMD Severity Scale Step 7 | 6 - AREDS AMD Severity Scale Step 6 |
| AR2_0898 | ED148650 | General Research Use | No | Male | White | 73 | 7 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_1029 | ED149607 | General Research Use | No | Female | White | 64 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_1095 | ED148887 | General Research Use | No | Female | White | 69 | 7 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_1173 | ED148189 | General Research Use | No | Female | White | 78 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_1204 | ED150025 | General Research Use | No | Male | White | 64 | 7 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_1236 | ED149259 | General Research Use | No | Female | White | 57 | 7 - AREDS AMD Severity Scale Step 7 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_1316 | ED149147 | General Research Use | No | Female | White | 72 | 7 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_1373 | ED148232 | Eye Disease Only | No | Female | White | 51 | 7 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_1397 | ED149466 | General Research Use | No | Male | White | 69 | 7 - AREDS AMD Severity Scale Step 5 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_1420 | ED149134 | General Research Use | No | Female | White | 76 | 7 - AREDS AMD Severity Scale Step 5 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |